Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Maetzig

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2016
Development of Inducible Molecular Switches Based on All-in-One Lentiviral Vectors Equipped with Drug Controlled FLP RecombinaseTobias Maetzig, Axel Schambach
Experimental Hematology|August 12, 2018
Fluorescent genetic barcoding for cellular multiplex analysesTobias Maetzig, Michael Morgan, Axel Schambach
Current Gene Therapy|September 1, 2012
Retroviral protein transfer: falling apart to make an impactTobias Maetzig, Christopher Baum, Axel Schambach
Viruses|October 14, 2011
Gammaretroviral vectors: biology, technology and applicationTobias Maetzig, Melanie Galla, Christopher Baum, et al.
Human Gene Therapy|June 18, 2021
An Improved Lentiviral Fluorescent Genetic Barcoding Approach Distinguishes Hematopoietic Stem Cell Properties in Multiplexed <i>In Vivo</i> ExperimentsAnna Lieske, Teng Cheong Ha, Axel Schambach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectorsAxel Schambach, Melanie Galla, Tobias Maetzig, et al.
Molecular Therapy. Advances|June 15, 2026
Lentiviral rescue of UMPS auxotrophy enables drug-free selection and stable vector expressionHenrike Steding, Nicole Dörpmund, Jessica Herbst, et al.
Journal of Virology|April 23, 2010
Self-inactivating alpharetroviral vectors with a split-packaging designJulia D Suerth, Tobias Maetzig, Melanie Galla, et al.
Human Gene Therapy|September 10, 2010
Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic rangeNiels Heinz, Axel Schambach, Melanie Galla, et al.
Human Gene Therapy|October 21, 2011
Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cellsChristine Voelkel, Melanie Galla, Philip N Dannhauser, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2016
Development of Inducible Molecular Switches Based on All-in-One Lentiviral Vectors Equipped with Drug Controlled FLP RecombinaseTobias Maetzig, Axel Schambach
Experimental Hematology|August 12, 2018
Fluorescent genetic barcoding for cellular multiplex analysesTobias Maetzig, Michael Morgan, Axel Schambach
Current Gene Therapy|September 1, 2012
Retroviral protein transfer: falling apart to make an impactTobias Maetzig, Christopher Baum, Axel Schambach
Viruses|October 14, 2011
Gammaretroviral vectors: biology, technology and applicationTobias Maetzig, Melanie Galla, Christopher Baum, et al.
Human Gene Therapy|June 18, 2021
An Improved Lentiviral Fluorescent Genetic Barcoding Approach Distinguishes Hematopoietic Stem Cell Properties in Multiplexed <i>In Vivo</i> ExperimentsAnna Lieske, Teng Cheong Ha, Axel Schambach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectorsAxel Schambach, Melanie Galla, Tobias Maetzig, et al.
Molecular Therapy. Advances|June 15, 2026
Lentiviral rescue of UMPS auxotrophy enables drug-free selection and stable vector expressionHenrike Steding, Nicole Dörpmund, Jessica Herbst, et al.
Journal of Virology|April 23, 2010
Self-inactivating alpharetroviral vectors with a split-packaging designJulia D Suerth, Tobias Maetzig, Melanie Galla, et al.
Human Gene Therapy|September 10, 2010
Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic rangeNiels Heinz, Axel Schambach, Melanie Galla, et al.
Human Gene Therapy|October 21, 2011
Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cellsChristine Voelkel, Melanie Galla, Philip N Dannhauser, et al.
Pageof 5